ID: ALA1630011

Max Phase: Preclinical

Molecular Formula: C15H16O3

Molecular Weight: 244.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](O)[C@H](O)C#CC#CC(O)Cc1ccccc1

Standard InChI:  InChI=1S/C15H16O3/c1-12(16)15(18)10-6-5-9-14(17)11-13-7-3-2-4-8-13/h2-4,7-8,12,14-18H,11H2,1H3/t12-,14?,15+/m0/s1

Standard InChI Key:  WSAAGMBUROLZKE-XSDATEAUSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 244.29Molecular Weight (Monoisotopic): 244.1099AlogP: 0.34#Rotatable Bonds: 3
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.37CX Basic pKa: CX LogP: 1.60CX LogD: 1.60
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.67Np Likeness Score: 1.35

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source